Research Article
A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy
Table 6
Average outcome measures for the different levels of final pain.
| Last reported VAS | % study sample (N = 240) | 7-day VAS (after 7-day treatment) | Δ VAS (baseline: last reported) | Δ QoL (baseline: last reported) | Δ sleep (baseline: last reported) | Δ medications (baseline: last reported) | Δ physical activity (baseline: last reported) | % stopped medication use | % stopped nondrug pain therapies |
| 0–1 | 18% | 1.43 | 7.41 | +5.48 | +2.22 | +3.02 | +2.18 | 34 | 23 | 2–3 | 39% | 2.71 | 5.54 | +5.07 | +1.99 | +2.5 | +1.86 | 16.5 | 17 | 4–5 | 28% | 3.59 | 3.91 | +4.6 | +1.76 | +2.02 | +1.4 | 13.5 | 14 | 6–7 | 12% | 4.31 | 2.58 | +3.95 | +1.23 | +0.57 | +0.98 | 0 | 13 | 8–10 | 3% | 5.00 | −0.33 | +3.50 | +1.00 | +0.50 | +0.83 | 0 | 0 |
|
|
Numerical values for the change measures can be found in Table 1. |